- Nielsen survey: Price most persuasive when incentivizing brand switch; improved features least influential
- CVS/pharmacy officially unveils new myWeekly Ad digital circular
- Mr. Clean gives Times Square a post-party scrub-down
- P&G's new Crest Be aims to offer 'unexpected experience'
- Major trend for 2014: Personalization
PALM CITY, Fla. — GelStat Corporation on Monday announced that it has retained List Services Corp. to manage all branding and marketing efforts for GelStat Corporation and its products, GelStat Migraine and GelStat Sleep. LSC is a direct marketing agency that has evolved from a list management and brokerage house into a full service solution.
"LSC and its team have a long-term proven track record of building and supporting leading brands [with] insight on how the convergence of big data and technology is affecting … marketing efforts and sales channels," stated Gerald Kieft, GelStat CEO. "Now that we have the right marketing team in place, I'm confident that we have the platform necessary to drive revenue and build shareholder value."
LSC, as its marketing partner, will act as GelStat's in-sourced marketing services group to build its brand of healthcare products and drive demand for those products through a number of communications and media channels. The effort will be led by LSC chief strategic officer Charlie Tarzian acting as GelStat's chief marketing officer.
Services provided by LSC will include strategic brand and communications channel planning, media planning and buying, media trafficking, creative services, data modeling and analytics, campaign management, reporting and reconciliation.
LSC will deploy a hybrid model that will include a small, retained group of senior marketing professionals that will be responsible for the day-to-day running and managing of the business; and a project-based, as-needed staff of marketing specialists that will be called upon across the various stages of the relationship to perform specific tasks and functions.
Find us on Facebook for more insight, analysis and the latest in drug store news.